Advanced neuroimaging techniques in the management of glioblastoma multiforme

Current Radiopharmaceuticals

Volumn 5, Issue 4, 2012, Pages 300-307

  Colonnese, Claudio ^a   Romanelli, Pantaleo ^b  

^a IRCCS NEUROMED   (Italy)

^b Brain Radiosurgery   (Italy)

Author keywords

Brain tumors; CT; Glioblastoma multiforme; MRI; Neuroimaging; Radiosurgery

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FRACTIONAL ANISOTROPY; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; NEUROIMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REVIEW; SPECTROSCOPY;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOVASCULARIZATION, PATHOLOGIC; NEUROIMAGING; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867698111     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205040300     Document Type: Review

References (19)

1. Baldi, I.; Huchet, A.; Bauchet, L.; Loiseau, H. Epidemiology of glioblastoma. Neurochirurgie, 2010, 56(6), 433-440.
2. nd ed.; Altona: Canada, 2009; Cap. 6, pp 19-22.
3. Wang, M.Y.; Cheng, J.L.; Han, Y.H.; Li, Y.L.; Dai, J.P.; Shi, D.P. Measurement of tumor size in adult glioblastoma: Classical crosssectional criteria on 2D MRI or volumetric criteria on high resolution 3D MRI? Eur. J. Radiol., 2011, doi: 10.1016/j.ejrad. 2011.05.017.
4. Hoisak, J.D.; Jaffray, D.A. A method for assessing voxel correspondence in longitudinal tumor imaging. Med. Phys., 2011, 38(5), 2742-2753.
5. Doskaliyev, A.; Yamasaki, F.; Ohtaki, M.; Kajiwara, Y.; Takeshima, Y.; Watanabe, Y.; Takayasu, T.; Amatya, VJ.; Akiyama, Y.; Sugiyama, K.; Kurisu, K. Lymphomas and glioblastomas: Differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur. J. Radiol., 2010, doi: 10.1016/j.ejrad.2010.11. 005.
6. Wang, S.; Kim, S.; Chawla, S.; Wolf, R.L.; Knipp, D.E.; Vossough, A.; O'Rourke, D.M.; Judy, K.D.; Poptani, H.; Melhem, E.R. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. Am. J. Neuroradiol., 2011, 32(3), 507-514.
7. Blasel, S.; Jurcoane, A.; Franz, K.; Morawe, G.; Pellikan, S.; Hattingen, E. Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir. (Wien), 2010, 152(11), 1893-1899.
8. Chawla, S.; Zhang, Y.; Wang, S.; Chaudhary, S.; Chou, C.; O'Rourke, D.M.; Vossough, A.; Melhem, E.R.; Poptani, H. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J. Comput. Assist. Tomogr., 2010, 34(6), 836-841.
9. Fellows, G.A.; Wright, A.J.; Sibtain, N.A.; Rich, P.; Opstad, K.S.; McIntyre, D.J.; Bell, B.A.; Griffiths, J.R.; Howe, F.A. Combined use of neuroradiology and 1H-MR spectroscopy may provide an intervention limiting diagnosis of glioblastoma multiformee. J. Magn. Reson. Imaging, 2010, 32(5), 1038-1044.
10. Saksena, S.; Jain, R.; Narang, J.; Scarpace, L.; Schultz, L.R.; Lehman, N.L.; Hearshen, D.; Patel, S.C.; Mikkelsen, T. Predicting survival in glioblastomas using diffusion tensor imaging metrics. J. Magn. Reson. Imaging, 2010, 32(4), 788-795.
11. Thu, M.S.; Najbauer, J.; Kendall, S.E.; Harutyunyan, I.; Sangalang, N.; Gutova, M.; Metz, M.Z.; Garcia, E.; Frank, R.T.; Kim, S.U.; Moats, R.A.; Aboody, K.S. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One, 2009, 4(9), e7218.
12. Byrnes, T.J.; Barrick, T.R.; Bell, B.A.; Clark, C.A. Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo. NMR Biomed., 2011, 24(1), 54-60.
13. Khayal, I.S.; Polley, M.Y.; Jalbert, L.; Elkhaled, A.; Chang, S.M.; Cha, S.; Butowski, N.A.; Nelson, S.J. Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiformee. NeuroOncol., 2010, 12(9), 908-916.
14. Leitzen, C.; Schild, H.H.; Bungart, B.; Herrlinger, U.; Lütter, C.; Müdder, T.; Wilhelm-Buchstab, T.; Schüller, H. [Prediction of clinical course of glioblastomas by MRI during radiotherapy]. Strahlenther Onkol., 2010, 186(12), 681-686.
15. Kim, H.; Catana, C.; Ratai, E.M.; Andronesi, O.C.; Jennings, D.L.; Batchelor, T.T.; Jain, R.K.; Sorensen, A.G. Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma. Cancer Res., 2011, 71(11), 3745-3752.
16. Essock-Burns, E.; Lupo, J.M.; Cha, S.; Polley, M.Y.; Butowski, N.A.; Chang, S.M.; Nelson, S.J. Assessment of perfusion MRIderived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma. NeuroOncol., 2011, 13(1), 119-131.
17. Young, R.J.; Gupta, A.; Shah, A.D.; Graber, J.J.; Zhang, Z.; Shi, W.; Holodny, A.I.; Omuro, A.M. Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma. Neurology, 2011, 76(22), 1918-1924.
18. Sawlani, R.N.; Raizer, J.; Horowitz, S.W.; Shin, W.; Grimm, S.A.; Chandler, J.P.; Levy, R.; Getch, C.; Carroll, T.J. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging-pilot study. Radiology. 2010, 255(2), 622-628.
19. Ellingson, B.M.; Cloughesy, T.F.; Lai, A.; Nghiemphu, P.L.; Mischel, P.S.; Pope, W.B. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. NeuroOncol., 2011, 13(4), 401-409.